Navigation Links
Important Information Regarding the Genetics of Alzheimer’s Disease and Dementia Announced by One Million Solutions in Health™
Date:1/31/2017

One Million Solutions in Health is proud to announce and share this webinar, “Genetics of Alzheimer's Disease and Dementia” by Dr. Arnold I. Pallay, FAAFP, Associate Director Jacobs Levy Personalized Genomic Medicine Program Atlantic Health System, Associate Clinical Professor Department of Family Medicine Rutgers Robert Wood Johnson Medical School and New Jersey Medical School Graduate School of Medicine, Seton Hall University.

As the population ages, increasing cases of dementia, especially Alzheimer’s type are uncovered and diagnosed. The genetics of these conditions are rapidly being elucidated and have been of interest to the scientific community and the lay public alike.

Genetic tests can suggest a higher degree of likelihood for patients to develop such conditions which, contrary to popular thought, is of value to patients in their normal routine of health care and preventative medicine.

This webinar focuses on the complex genetics that seem to make us prone to such conditions as we age. Review the webinar here: Genetics of Alzheimer's Disease and Dementia.

ABOUT ONE MILLION SOLUTIONS IN HEALTH:

As a not-for-profit, the goal of One Million Solutions in Health™ is to shape health care by sharing solutions and, importantly, to accelerate the discovery, development and delivery ... of innovative cures, treatments and preventative measures for patients around the world. By facilitating efforts to ensure organizations can Connect, Learn + Share, Innovate and Collaborate, our vision is to improve health care delivery, accelerate life sciences research and share patient and consumer-focused ideas and solutions.

By engaging scientists, entrepreneurs, investors, innovators, industry experts, health care professionals, and patients across various disciplines, and from around the world, we can utilize the power of the internet to disrupt things in a positive and transformative way to accelerate the movement of new solutions and scientific discoveries from the scientist to the patient.

The Technology Evaluation Consortium (TEC) brings together life sciences and/or health care companies and technology providers, and other relevant partners (e.g., government and Universities) to evaluate and validate technologies or services in a collaborative environment. The model empowers technology providers and industry end users to collectively assess a number of technologies in a cost-effective manner, producing a depth and breadth of results that no company can achieve alone.

We are on our way towards accelerating high-potential innovations, catalyzing investment and increasing awareness of, and support for, important ideas to improve health and save lives. We are thrilled to have you be a part of this transformative journey!

IF YOU HAVE A TECHNOLOGY, SCIENTIFIC DISCOVERY OR MEDICAL SOLUTION YOU WOULD LIKE US TO HELP SHARE WITH THE WORLD, CONTACT US.

For more information: http://www.onemillionsolutionsinhealth.org

CONTACT:

One Million Solutions in Health™
Dawn Van Dam
Executive Director & CEO
Email: dawn.vandam(at)onemillionsolutionsinhealth(dot)org
Phone: 416-402-8274
Twitter: @DawnVanDam

Read the full story at http://www.prweb.com/releases/2017/02/prweb14028811.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Aurigenes Collaboration Programs with Endo Pharmaceuticals Reach Important Milestones
2. How to Autoclave: Why the User Friendliness of the Saniclave 200 is So Important Today
3. Important breakthrough in identifying effect of epilepsy treatment
4. York researchers discover important mechanism behind nanoparticle reactivity
5. Respiratory Update: Interpreting Minimal Clinically Important Differences in COPD and Demonstrating Product Value with PROs, a New Life Science webinar Hosted by Xtalks
6. September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month!
7. Green Dot To Sponsor “Zero Waste” Fashion Show at the Plastics Industry’s Most Important Trade Event
8. Australian Studies Confirm Anisina as Potential Important New Weapon Against Melanoma
9. BioAmber Achieves Important Milestone: Sarnia Construction Substantially Complete
10. DOE (Department of Energy) Reports that Direct AC LED Technology and High-Voltage LEDs are Important for the Future of SSL
11. RepliCel Receives Two Important Approvals for Dermal Rejuvenation Clinical Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... 26, 2017 , ... WonderWorks, Myrtle Beach’s science focused amusement ... of deep space exploration and inspire space enthusiasts. The exhibit features interactive exhibits ... guest appearance by former Shuttle Astronaut Don Thomas. , The intergalactic weekend kicks ...
(Date:4/26/2017)... ... April 26, 2017 , ... As the call ... healthcare industry stakeholders, the discussion surrounding the topic will continue at WEDI 2017- ... in Los Angeles, Calif. Hosted by the Workgroup for Electronic Data Interchange (WEDI), ...
(Date:4/25/2017)... R.I. , April 25, 2017 ... Inc. ("EpiVax") has licensed its novel immune-modulating technology to ... autoimmune disease and allergy. Tregitopes, pronounced ... in human immunoglobulin by EpiVax CEO Annie ... Similar to intravenous immunoglobulin G, an autoimmune disease ...
(Date:4/24/2017)... , April 24, 2017  Dante Labs announced today the ... EUR 850 (ca. $900). While American individuals have been able ... time Europeans can access WGS below EUR 1,000. ... to leveraging genetic information to make informed decisions about disease ... ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute for ... Cell Explorer: a one-of-a-kind portal and dynamic digital window ... imaging data, the first application of deep learning to ... stem cell lines and a growing suite of powerful ... for these and future publicly available resources created and ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/29/2017)... 29, 2017  higi, the health IT company that ... North America , today announced a Series B ... of EveryMove. The new investment and acquisition accelerates higi,s ... to transform population health activities through the collection and ... higi collects and secures data today on behalf ...
Breaking Biology News(10 mins):